Breaking News Instant updates and real-time market news.

CC

Chemours

$23.62

0.87 (3.82%)

, DOW

Dow Chemical

$53.99

-0.33 (-0.61%)

04:55
11/30/16
11/30
04:55
11/30/16
04:55

Citigroup to hold a conference

Basic Materials Conference is being held in New York on November 29-30.

CC

Chemours

$23.62

0.87 (3.82%)

DOW

Dow Chemical

$53.99

-0.33 (-0.61%)

PPG

PPG Industries

$98.00

0.65 (0.67%)

ECL

Ecolab

$116.41

0.07 (0.06%)

LYB

LyondellBasell

$83.72

-1.86 (-2.17%)

EMN

Eastman Chemical

$73.69

-0.42 (-0.57%)

PX

Praxair

$122.18

3.49 (2.94%)

PAH

Platform Specialty Products

$9.25

0.36 (4.05%)

OI

Owens-Illinois

$18.10

-0.01 (-0.06%)

HUN

Huntsman

$19.05

0.43 (2.31%)

TROX

Tronox

$11.38

0.38 (3.45%)

MOS

Mosaic

$27.06

-0.01 (-0.04%)

MON

Monsanto

$102.39

0.36 (0.35%)

PHM

PulteGroup

$19.29

0.19 (0.99%)

FMC

FMC Corporation

$54.80

-0.34 (-0.62%)

MDC

M.D.C. Holdings

$27.25

0.34 (1.26%)

ICL

Israel Chemicals

$3.75

0.03 (0.81%)

APD

Air Products

$143.47

1.69 (1.19%)

SUM

Summit Materials

$23.55

0.23 (0.99%)

WRK

WestRock

$50.89

-0.03 (-0.06%)

  • 30

    Nov

  • 30

    Nov

  • 05

    Dec

  • 06

    Dec

  • 13

    Dec

  • 19

    Dec

  • 27

    Jan

CC Chemours
$23.62

0.87 (3.82%)

07/06/16
SUSQ
07/06/16
NO CHANGE
SUSQ
Jury ruling a significant setback for Chemours, says Susquehanna
After a jury found that DuPont (DD) is liable in a case evaluating whether drinking water tainted with C8, a chemical used in the manufacturing of Teflon, caused a plaintiff's testicular cancer, Susquehanna called the ruling a significant setback for Chemours (CC). The jury not only awarded compensatory damages, but also determined that punitive damages are warranted, noted the firm, which pointed out that Chemours is the real party at risk, as it must indemnify DuPont for all of these PFOA litigation damages, with this trial representing only the third of 3,512 personal injury and 30 wrongful death cases facing the companies. Chemours shares are near their session lows, down about 19% in late afternoon trading following news of the jury ruling.
03/14/16
GSCO
03/14/16
UPGRADE
Target $10
GSCO
Buy
Chemours upgraded to Buy from Neutral at Goldman
Goldman analyst Robert Koort Chemours to Buy and raised his price target to $10 from $6. The analyst upgraded shares based on valuation, signs that the TiO2 market is bottoming, progress on PFOA, and cost cutting and asset monetization efforts that should help drive 2016 earnings momentum.
08/10/16
ARGS
08/10/16
UPGRADE
ARGS
Buy
Chemours upgraded on competitive advantages, valuation at Argus
As noted earlier, Argus upgraded Chemours to Buy from Hold. Analyst David Coleman believes that the company "has significant competitive advantages," while its valuation is "favorable." Target $13.
08/10/16
ARGS
08/10/16
UPGRADE
ARGS
Buy
Chemours upgraded to Buy from Hold at Argus
DOW Dow Chemical
$53.99

-0.33 (-0.61%)

10/03/16
SBSH
10/03/16
UPGRADE
SBSH
Buy
Citi upgrades Dow and DuPont, says DowDuPont could be 'stock to own' in 2017
As previously reported, Citi analyst P.J. Juvekar upgraded shares of both Dow Chemical (DOW) and DuPont (DD), each to Buy from Hold, citing their "massive" cost-cutting opportunity after their proposed merger goes through as well as the potential for upside to the companies' stated $3B synergy target. If their deal gets completed, the combined Dow-DuPont would "be the stock to own in 2017," said Juvekar, who raised the firm's price target on DuPont shares to $76 from $72 and increased the target for Dow shares to $59 from $55.
10/03/16
10/03/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Dow Chemical (DOW) and DuPont (DD) were upgraded to Buy from Neutral at Citi with analyst P.J. Juvekar citing he opportunity presented by the proposed merger. 2. Freeport McMoRan (FCX), Barrick Gold (ABX), and Pan American Silver (PAAS) were upgraded to Buy from Hold at Deutsche Bank. 3. LogMeln (LOGM) upgraded to Overweight from Equal Weight at Barclays with analyst Raimo Lenschow saying the pending merger with Citrix's (CTXS) divested GoTo assets creates a "great new opportunity." 4. Halliburton (HAL) upgraded to Buy from Hold at Societe General. 5. Coty (COTY) upgraded to Buy from Neutral at BofA/Merrill with analyst Olivia Tong saying she believes Coty is at the beginning of a potential transformation with the pending closure of the P&G Beauty deal this week that could bring increased scale as well as a more targeted operational structure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/16
UBSW
10/10/16
UPGRADE
Target $62
UBSW
Buy
Dow Chemical upgraded to Buy from Neutral at UBS
UBS analyst John Roberts upgraded Dow Chemical (DOW) to Buy saying the merger with DuPont (DD) could gain regulatory approval and that the stock is "now too cheap to ignore." The analyst sees $3B in potential cost savings and expects improving cash flow. Roberts raised his price target for the shares to $62 from $53.
10/10/16
10/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mylan (MYL) upgraded to Strong Buy from Market Perform at Raymond James with Elliot WIlbur saying the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. 2. Under Armour (UA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Tom Nikic saying "noise" from the Sports Authority's bankruptcy is fading while distribution expansion could lead to sales re-acceleration over the next 12-18 months. 3. Deere (DE) and AGCO (AGCO) were upgraded to Outperform from Market Perform at Wells Fargo. 4. Dow Chemical (DOW) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the merger with DuPont (DD) could gain regulatory approval and that the stock is "now too cheap to ignore." 5. Exelixis (EXEL) upgraded to Overweight from Neutral at Piper Jaffray with analyst Edward Tenthoff saying the data are "good enough" to file a supplemental new drug application and could drive off-label front-line RCC use. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PPG PPG Industries
$98.00

0.65 (0.67%)

10/11/16
DBAB
10/11/16
DOWNGRADE
Target $100
DBAB
Hold
PPG Industries downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst David Begleiter downgraded PPG Industries to Hold saying the company's "modest" earnings growth in 2016 will continue into 2017. The analyst, however, views the stock as "slightly oversold" following Friday's Q3 preannounced shortfall. Begleiter cut his price target for the shares to $100 from $122.
10/20/16
GSCO
10/20/16
DOWNGRADE
Target $103
GSCO
Neutral
PPG Industries downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Robert Koort downgraded PPG Industries to Neutral citing a lack of catalysts following the company's first negative preannouncement in eight years. The analyst finds the valuation attractive but highlights moderating global auto sales and "lackluster" growth in Europe. Koort cut his price target for the stock to $103 from $111.
10/25/16
ARGS
10/25/16
DOWNGRADE
ARGS
Hold
PPG Industries downgraded to Hold from Buy at Argus
Argus analyst Bill Selesky downgraded PPG Industries to Hold to reflect management's reduced Q3 guidance in early October and the subsequent report of a year-over-year decline in Q3 earnings. The analyst lowered estimates to reflect management's tepid outlook for the rest of the year.
10/10/16
DBAB
10/10/16
DOWNGRADE
DBAB
Hold
PPG Industries downgraded to Hold from Buy at Deutsche Bank
ECL Ecolab
$116.41

0.07 (0.06%)

08/25/16
MACQ
08/25/16
INITIATION
Target $143
MACQ
Outperform
Ecolab initiated with an Outperform at Macquarie
Macquarie analyst Hamzah Mazari initiated Ecolab with an Outperform and $143 price target.
08/03/16
OPCO
08/03/16
NO CHANGE
Target $129
OPCO
Outperform
Ecolab price target raised to $129 from $120 at Oppenheimer
Oppenheimer analyst Scott Schneeberger raised his price target for Ecolab to $129 from $120 following the company's quarterly results. The analyst is encouraged by "solid" performance across Ecolab's non-Energy segments, and the potential the Energy segment is near-trough as year over year comps begin to ease in the second half of 2016. Schneeberger reiterates an Outperform rating on the shares.
11/02/16
OPCO
11/02/16
NO CHANGE
Target $120
OPCO
Outperform
Ecolab price target lowered to $120 from $129 at Oppenheimer
Oppenheimer analyst Scott Schneeberger lowered his price target for Ecolab to $120 from $129 on valuation after the company reported in-line Q3 EPS. The analyst is also tempering his 2017 adjusted EPS estimates on more conservative revenue assumptions, but says he still anticipates accelerated growth in 2017 as 2016 energy/forex headwinds moderate. Schneeberger reiterates an Outperform rating on the shares.
08/03/16
SBSH
08/03/16
UPGRADE
Target $141
SBSH
Buy
Ecolab upgraded to Buy from Neutral at Citi
Citi analyst P.J. Juvekar upgraded Ecolab to Buy saying the company's Energy business is nearing an inflection point. A pick-up in energy segment growth off low comps could provide a boost to earnings growth, Juvekar tells investors in a research note. He raised his price target for the shares to $141 from $127 following Ecolab's Q2 results.
LYB LyondellBasell
$83.72

-1.86 (-2.17%)

10/13/16
TUDR
10/13/16
INITIATION
Target $95
TUDR
Buy
LyondellBasell initiated with a Buy at Tudor Pickering
Tudor Pickering analyst Matthew Blair initiated LyondellBasell with a Buy and a $95 price target.
06/27/16
06/27/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on the today's top five analyst downgrades with this list compiled by The Fly: 1. UBS (UBS) downgraded to Underweight from Neutral by JPMorgan analyst Kian Abouhossein, who cut his estimates for European banks following the Brexit vote. The analyst also downgraded Barclays (BCS) Deustche Bank (DB), Lloyds Banking (LYG) and Credit Suisse (CS) to Neutral from Overweight and RBS (RBS) to Underweight from Neutral. Barclays was also downgraded at Jefferies, BofA/Merrill and Exane BNP Paribas, RBS was also downgraded at RBC Capital, Societe Generale, Jefferies, BofA/Merrill and Exane BNP Paribas and Lloyds was also downgraded at Barclays and BofA/Merrill. 2. Fiat Chrysler (FCAU) downgraded to Buy from Conviction Buy at Goldman by analyst Stefan Burgstaller, who cited slower European volume growth, a weaker North American market outlook in out years and updated currency assumptions following the UK referendum. The analyst cut his price target for the shares to $8 from $12.80. 3. LyondellBasell (LYB) downgraded to Sector Perform from Outperform at RBC Capital by analyst Arun Viswanathan, who sees limited near-term catalysts given soft ethylene and polyethylene momentum and is cautious on the large increase of ethylene capacity in 2017/18 and potentially higher ethane prices, combined with higher capex needs. The analyst cut his price target to $84 from $100. 4. AGCO (AGCO) downgraded to Underweight from Neutral at JPMorgan by analyst Ann Duignan, who cited weakening fundamentals in European agriculture. The company has the greatest exposure to Europe in our Machinery coverage, Duignan told investors in a research note. She cut her price target for the shares to $44 from $47. The analyst this morning also downgraded PACCAR (PCAR) and Parker-Hannifin (PH) to Underweight from Neutral. 5. NXP Semiconductors (NXPI) downgraded to Neutral from Buy at BofA/Merrill by analysts led by Vivek Arya, who lowered his price target to $90 from $100. Analysts lowered estimates given the company's heavy exposure to the Auto segment and industrial/infrastructure segment and likely pressure on top-line growth from Brexit. The analyst is less confidence NXP can grow top line year-over-year in 2016/17 and said the Freescale (FSL) acquisition and shareholder sales creates an overhang. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/16
RBCM
06/27/16
DOWNGRADE
Target $84
RBCM
Sector Perform
LyondellBasell downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Arun Viswanathan downgraded LyondellBasell to Sector Perform and lowered its price target to $84 from $100. The analyst sees limited near-term catalysts given soft ethylene and polyethylene momentum and is cautious on the large increase of ethylene capacity in 2017/18 and potentially higher ethane prices, combined with higher capex needs.
06/23/16
JPMS
06/23/16
DOWNGRADE
Target $80
JPMS
Neutral
LyondellBasell downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded LyondellBasell to Neutral from Overweight citing his expectations for increased capital expenditures and the fact that ethane now trades at a premium to its fuel value. Zekauskas lowered his price target on LyondellBasell shares to $80 from $100.
EMN Eastman Chemical
$73.69

-0.42 (-0.57%)

08/02/16
RBCM
08/02/16
DOWNGRADE
RBCM
Sector Perform
Eastman Chemical downgraded on pricing, tow performance at RBC Capital
As noted earlier, RBC Capital downgraded Eastman Chemical to Sector Perform from Outperform. Analyst Arun Viswanathan,says he has been disappointed by the company's "sluggish downstream pricing and acetate tow performance." Target to $70 from $83.
09/07/16
SBSH
09/07/16
DOWNGRADE
Target $73
SBSH
Neutral
Eastman Chemical downgraded to Neutral from Buy at Citi
Citi analyst P.J. Juvekar downgraded Eastman Chemical (EMN) to Neutral saying he sees earnings growth risks from a secular decline in the "once dependable" filter tow business, which is used in cigarette filters. The analyst cut his price target for the shares to $73 from $74 and notes his 2017 earnings estimates are now below consensus. Juvekar this morning also downgraded Celanese (CE) to Neutral citing a similar rationale.
09/07/16
09/07/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Discover (DFS) downgraded to Equal Weight from Overweight at Barclays with analyst Mark DeVries downgrading the stock after lowering his rating on the U.S. Consumer Finance sector to Neutral from Positive. 2. Eastman Chemical (EMN) and Celanese (CE) were downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying he sees earnings growth risks from a secular decline in the "once dependable" filter tow business, which is used in cigarette filters. 3. Royal Caribbean (RCL) downgraded to Hold from Buy at Argus with analyst John Staszak citing the company's outlook for higher fuel costs and foreign exchange headwinds. 4. Accuride (ACW) downgraded to Hold from Buy at Gabelli. 5. Dollar General (DG) downgraded to Underperform from Peer Perform at Wolfe Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/02/16
RBCM
08/02/16
DOWNGRADE
RBCM
Sector Perform
Eastman Chemical downgraded to Sector Perform from Outperform at RBC Capital
PX Praxair
$122.18

3.49 (2.94%)

03/24/16
FBCO
03/24/16
NO CHANGE
Target $117
FBCO
Neutral
Praxair assumed with a Neutral at Credit Suisse
Credit Suisse analyst Christopher Parkinson assumed coverage on Praxair with a Neutral rating and increased the price target to $117 from $107.
04/04/16
DBAB
04/04/16
DOWNGRADE
Target $120
DBAB
Hold
Praxair downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst David Begleiter downgraded Praxair to Hold but raised his price target for the shares to $120 from $114.
02/02/16
02/02/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Agnico Eagle (AEM) downgraded to Hold from Buy at Desjardins... Alere (ALR) downgraded to Hold from Buy at Canaccord... Antero Resources (AR) downgraded to Reduce from Neutral at SunTrust... Carbylan (CBYL) downgraded to Market Perform from Outperform at Leerink... Copa Holdings (CPA) downgraded to Hold from Buy at Deutsche Bank... Dominion (D) downgraded to Neutral from Buy at Citi... Duke Energy (DUK) downgraded to Market Perform from Outperform at Wells Fargo... Hain Celestial (HAIN) downgraded to Neutral from Overweight at Piper Jaffray... Integrated Device (IDTI) downgraded to Neutral from Buy at BofA/Merrill... Logitech (LOGI) downgraded to Underweight from Equal Weight at Morgan Stanley... Merus Labs (MSLI) downgraded to Sector Perform from Outperform at Scotiabank... New Gold (NGD) downgraded to Sell from Buy at Desjardins... Nokia (NOK) downgraded to Underperform from Buy at CLSA... Plantronics (PLT) downgraded to Underperform from Outperform at Raymond James... Pool Corp. (POOL) downgraded to Equal Weight from Overweight at Stephens... Praxair (PX) downgraded to Sector Weight from Overweight at KeyBanc... Rofin-Sinar (RSTI) downgraded to Neutral from Buy at Longbow... Southwestern Energy (SWN) downgraded to Neutral from Overweight at JPMorgan... Stifel cuts Twitter (TWTR) to Sell after noting Yahoo has significantly more users... Superior Energy (SPN) downgraded to In-Line from Outperform at Imperial Capital... Sysco (SYY) downgraded to Underweight from Equal Weight at Morgan Stanley... Telenor (TELNY) downgraded to Underperform from Neutral at Credit Suisse... Twitter (TWTR) downgraded to Sell from Hold at Stifel... Valeo (VLEEY) downgraded to Underweight from Equal Weight at Morgan Stanley.
08/16/16
JEFF
08/16/16
NO CHANGE
Target $140
JEFF
Buy
Jefferies sees 20% probability of Praxair, Linde merger
Following the Wall Street Journal's report last night, Jefferies analyst Laurence Alexander pegs a potential merger between Praxair (PX) and Linde (LNEGY) at 20%. The analyst estimates Praxair could pay a 26% control premium, 50% equity, and still achieve an 8% return on invested capital in the third year and improve free cash flow per share by $1.70. Alexander has a Buy rating on Praxair with a $140 price target.
PAH Platform Specialty Products
$9.25

0.36 (4.05%)

08/22/16
ROTH
08/22/16
INITIATION
Target $12
ROTH
Buy
Platform Specialty Products initiated with a Buy at Roth Capital
Roth Capital analyst Joe Reagor started Platform Specialty Products with a Buy rating and $12 price target.
07/12/16
07/12/16
NO CHANGE

Platform Specialty Products files $1B mixed securities shelf
07/28/16
SBSH
07/28/16
INITIATION
Target $11
SBSH
Buy
Platform Specialty Products initiated with a Buy at Citi
Citi analyst Daniel Jester started Platform Specialty Products with a Buy rating and $11 price target.
11/07/16
NOMU
11/07/16
UPGRADE
Target $11
NOMU
Buy
Platform Specialty Products upgraded to Buy from Neutral at Nomura
Nomura analyst Aleksey Yefremov upgraded Platform Specialty Products to Buy and lowered its price target to $11 from $12 citing deep valuation discount and free cash flow growth.
OI Owens-Illinois
$18.10

-0.01 (-0.06%)

09/29/16
RBCM
09/29/16
INITIATION
RBCM
Sector Perform
Owens-Illinois initiated with a Sector Perform at RBC Capital
04/06/16
04/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CRH (CRH) upgraded to Overweight at JPMorgan by analyst Elodie Rall, who views the valuation as attractive and sees limited risk to estimates. 2. Ironwood (IRWD) upgraded to Outperform at Cowen citing the company's pipeline and ex-U.S. royalties as well as U.S. co-marketing agreements leaving room for growth. 3. Owens-Illinois (OI) upgraded to Buy at Citi with analyst Anthony Pettinari citing valuation and a low bar set by management for 2016. 4. Pennsylvania REIT (PEI) upgraded to Outperform at Boenning & Scattergood by analyst Floris van Dijkum, who believes Pennsylvania REIT's discounted valuation is unwarranted given significant acceleration in 2018 NOI growth. van Dijkum expects the company to continue to reduce leverage by selling other non-core assets and make development progress on the Fashion Outlets of Philadelphia. 5. Cisco (CSCO) upgraded to Neutral at JPMorgan with analyst Rod Hall saying the company's 3.8% dividend yield is "compelling in the midst of current market volatility." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/12/16
GSCO
05/12/16
INITIATION
Target $18
GSCO
Sell
Owens-Illinois initiated with a Sell at Goldman
Goldman analyst Brian Maguire initiated Owens-Illinois with a Sell and $18 price target.
05/12/16
05/12/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amarin (AMRN) assumed with a Buy at Jefferies by analyst Hugo Ong, who said off-label Vascepa promotion in mixed dyslipidemia may be beginning to bear fruit. 2. Theravance Biopharma (TBPH) initiated with an Outperform at Leerink with analyst Paul Matteis saying he sees a favorable risk/reward ahead of a string of clinical/commercial catalysts over the next year. 3. Graphic Packaging (GPK) initiated with a Conviction Buy at Goldman. 4. Owens-Illinois (OI) initiated with a Sell at Goldman. 5. Sonoco Products (SON) initiated with a Neutral at Goldman. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HUN Huntsman
$19.05

0.43 (2.31%)

07/11/16
NOMU
07/11/16
NO CHANGE
NOMU
Buy
Olin and Huntsman remain Top Picks for 2H 2016 at Nomura
Nomura analyst Aleksey Yefremov said Olin (OLN) and Huntsman (HUN) remain Top Picks heading into 2H 2016. The analyst sees stronger evidence of recovery in chlor-alkali and TiO2, combined with above-average FCF yields for both Buy rated names.
03/07/16
UBSW
03/07/16
NO CHANGE
Target $14
UBSW
Buy
Huntsman shares offer compelling opportunity, says UBS
UBS said Huntsman shares offer a compelling opportunity, citing the earnings potential of its cyclical businesses and its review of alternatives for its TiO2 division. UBS reiterated its Buy rating and $14 price target on Huntsman shares.
02/11/16
KEYB
02/11/16
DOWNGRADE
KEYB
Sector Weight
Huntsman downgraded to Sector Weight from Overweight at KeyBanc
TROX Tronox
$11.38

0.38 (3.45%)

04/06/16
04/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hibbett Sports (HIBB) downgraded to Underperform at BofA/Merrill citing the impact of the rapid growth of competitor and vendor owned e-commerce in its core small niche markets. BofA said Hibbett plans to build an e-commerce platform which is expected to launch in FQ4 2018, but it will likely negatively impact EBIT margins and earnings growth. 2. Tronox (TROX) downgraded to Sell at UBS by analyst John Roberts, who expects earnings for TiO2 producers to remain challenged in 2016. 3. EOG Resources (EOG) downgraded to Hold at Stifel based on "heightened oil price risk" amid what it sees as "mixed signals from OPEC ministers, ramping volumes from Iran, and potential backlash from Saudi Arabia." 4. Domtar (UFS) downgraded to Underperform from Neutral at BofA/Merrill. 5. Jernigan Capital (JCAP) downgraded to Sell from Hold at Wunderlich. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/06/16
UBSW
04/06/16
DOWNGRADE
Target $2.75
UBSW
Sell
Tronox downgraded to Sell from Neutral at UBS
UBS analyst John Roberts downgraded Tronox to Sell citing the stock's 75% rally over the past two months. The analyst expects earnings for TiO2 producers to remain challenged in 2016. He keeps a $2.75 price target for Tronox shares.
MOS Mosaic
$27.06

-0.01 (-0.04%)

10/24/16
VERT
10/24/16
NO CHANGE
VERT
Mosaic reiterated as a Sell at Vertical Research
Vertical Research analyst Sandy Klugman said nitrogen and potash prices have shown signs of bottoming in recent weeks, but phosphate prices continue to soften and likely to remain under pressure given weak global demand and more than ample supplies. Against this backdrop, the analyst maintains a Sell rating on Mosaic and revised its price target to $20.
11/02/16
11/02/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Outperform from Neutral at Credit Suisse with analyst Paul Condra raising estimates to reflect the company's solid third quarter results. Condra continues to believe Square is exposed to strong secular headwinds and its years of product investment and brand building put it ahead of the competition. 2. Enphase Energy (ENPH) upgraded to Outperform from Perform at Oppenheimer and to Outperform from Market Perform at Avondale. 3. Etsy (ETSY) upgraded to Buy from Neutral at Roth Capital with analyst Darren Aftahi saying he believes inherent operating leverage and the international opportunity in Etsy's model is "too compelling." 4. Mosaic (MOS) upgraded to Buy from Outperform at CLSA with analyst Mark Connelly citing valuation and stabilizing results. 5. Quotient Technology (QUOT) upgraded to Outperform from Sector Perform at RBC Capital and to Buy from Hold at Maxim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/16
11/02/16
UPGRADE

Buy
Mosaic upgraded to Buy on improving scale at CLSA
As previously reported, CLSA upgraded Mosaic to Buy from Outperform and maintained its $30 price target. Analyst Mark Connelly said market expectations already reflect a slow recovery and likes the fact that the company is increasing commodity exposure rather than decreasing it. He expects a distribution bounce back from two disappointing quarters and sees risks declining.
11/02/16
LYON
11/02/16
UPGRADE
Target $30
LYON
Buy
Mosaic upgraded to Buy from Outperform at CLSA
CLSA analyst Mark Connelly upgraded Mosaic to Buy citing valuation and stabilizing results and maintained its $30 price target.
MON Monsanto
$102.39

0.36 (0.35%)

09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded on acquisition at Bernstein
As noted earlier, Bernstein upgraded Monsanto (MON) to Market Perform from Underperform. Analyst Jonas Oxgaard upgraded the stock after Bayer (BAYRY) agreed to buy Monsanto. However, he warned that "it's too early to tell" whether regulators will approve the deal, and he says that the risk is "skewed to the downside in the near-term." He recommends that investors avoid the stock for 6-9 months. Target to $105 from $90.
11/18/16
OTRG
11/18/16
UPGRADE
OTRG
Mixed
Monsanto upgraded to Mixed from Negative at OTR Global
09/27/16
GSCO
09/27/16
UPGRADE
GSCO
Neutral
Monsanto upgraded to Neutral from Sell at Goldman
09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded to Market Perform from Underperform at Bernstein
PHM PulteGroup
$19.29

0.19 (0.99%)

09/29/16
WELS
09/29/16
INITIATION
WELS
Market Perform
PulteGroup initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Stephen East started PulteGroup with a Market Perform rating and $18-$22 price target range.
09/28/16
WELS
09/28/16
INITIATION
WELS
Market Perform
PulteGroup initiated with a Market Perform at Wells Fargo
09/19/16
WEDB
09/19/16
INITIATION
Target $16
WEDB
Underperform
PulteGroup initiated with an Underperform at Wedbush
Wedbush analyst Jay McCanless initiated PulteGroup with an Underperform and a $16 price target.
11/14/16
EVER
11/14/16
INITIATION
Target $18
EVER
Hold
PulteGroup initiated with a Hold at Evercore ISI
Evercore ISI analyst Stephen Kim initiated PulteGroup with a Hold and a $18 price target.
FMC FMC Corporation
$54.80

-0.34 (-0.62%)

11/04/16
FBCO
11/04/16
UPGRADE
FBCO
Outperform
FMC Corporation upgraded to Outperform from Neutral at Credit Suisse
05/19/16
JEFF
05/19/16
NO CHANGE
Target $95
JEFF
Hold
Jefferies views Bayer buyout of Monsanto as 'relatively unlikely'
After Monsanto (MON) confirmed an unsolicited offer from Bayer (BAYRY), Jefferies analyst Laurence Alexander says he still believes a transaction is "relatively unlikely." The analyst expects Monsanto to object to Bayer's offer given its conviction in its research and development pipeline and longer-term competitive advantages. Shares of Syngenta (SYT) and DuPont (DD) could be pressured as regulatory scrutiny is likely to intensify should Monsanto get acquired, and BASF (BASFY) could sell off on investor concerns of a potential counter-bid, Alexander tells investors in a research note. On the other hand, he sees a potential Monsanto takeover as positive for shares of Novozymes (NVZMY) and FMC Corporation (FMC). "A further roll-up of 'specialty generic' agrichemical assets could entice capital, and FMC would be a plausible anchor for such an attempt," the analyst writes. He has a Hold rating on Monsanto with a $95 price target.
11/28/16
PIPR
11/28/16
UPGRADE
Target $51
PIPR
Neutral
FMC Corporation upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Brett Wong upgraded FMC Corporation and others in the Agriculture space to Neutral saying investors will likely continue to pay "lofty multiples" since a bottom of the cycle is close. The analyst raised his price target for the shares to $51 from $45.
11/04/16
11/04/16
UPGRADE
Target $57

Outperform
FMC Corporation upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse upgraded FMC Corporation to Outperform from Neutral and raised its price target to $57 from $48. Analyst Christopher Parkinson still has modest concerns regarding ag headwinds but said they are offset from enhanced distribution channels, dynamic pricing models and upside from lithium.
MDC M.D.C. Holdings
$27.25

0.34 (1.26%)

09/28/16
WELS
09/28/16
INITIATION
WELS
Market Perform
M.D.C. Holdings initiated with a Market Perform at Wells Fargo
08/08/16
DBAB
08/08/16
DOWNGRADE
Target $27
DBAB
Hold
M.D.C. Holdings downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Nishu Sood downgraded M.D.C. Holdings to Hold saying the maturing housing cycle will limit the stock's returns. The analyst lowered his price target for the shares to $27 from $28.
09/29/16
WELS
09/29/16
INITIATION
WELS
Market Perform
M.D.C. Holdings initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Stephen East started M.D.C. Holdings with a Market Perform rating and $23-$28 price target range.
11/14/16
EVER
11/14/16
INITIATION
Target $28
EVER
Hold
M.D.C. Holdings initiated with a Hold at Evercore ISI
Evercore ISI analyst Stephen Kim initiated M.D.C. Holdings with a Hold and a $28 price target.
ICL Israel Chemicals
$3.75

0.03 (0.81%)

12/17/15
GSCO
12/17/15
UPGRADE
GSCO
Neutral
Israel Chemicals upgraded to Neutral from Sell at Goldman
APD Air Products
$143.47

1.69 (1.19%)

11/21/16
ARGS
11/21/16
UPGRADE
ARGS
Buy
Air Products upgraded to Buy from Hold at Argus
11/21/16
ARGS
11/21/16
UPGRADE
ARGS
Buy
Air Products upgraded on postive moves at Argus
As noted earlier, Argus upgraded Air Products to Buy from Hold. As reasons for the upgrade, analyst Bill Selesky cited the spinoff of the company's Electronic Materials division, the forthcoming sale of its Performance Materials division, and other restructuring actions it has taken over the last year. Going forward, he expects the company to use the proceeds from asset sales to make "small to medium-sized acquisitions" and carry out stock buybacks and dividend increases. Target $159.
11/21/16
11/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KBR (KBR) upgraded to Buy from Neutral at MKM Partners with analyst Daniel Scott saying the new business mix emphasizing government services and technology de-risks the model and warrants a re-rating. 2. Air Products (APD) upgraded to Buy from Hold at Argus with analyst Bill Selesky citing the spinoff of the company's Electronic Materials division, the forthcoming sale of its Performance Materials division, and other restructuring actions it has taken over the last year. 3. Fossil (FOSL) upgraded to Neutral from Underweight at Piper Jaffray with analyst Erinn Murphy saying the company has an opportunity to cut costs and its potential with hybrid watches is being underappreciated. 4. HSBC (HSBC) upgraded to Market Perform from Underperform at Bernstein. 5. Leidos (LDOS) upgraded to Outperform from Neutral at Credit Suisse with analyst Robert Springarn saying he sees further upside for Leidos driven by the IS&GS acquisition from cost synergies, deleveraging, and potential revenue synergies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
ATLE
09/30/16
UPGRADE
ATLE
Neutral
Air Products upgraded to Neutral from Underweight at Atlantic Equities
SUM Summit Materials
$23.55

0.23 (0.99%)

04/01/16
RBCM
04/01/16
NO CHANGE
RBCM
Summit Materials price target raised to $23 from $18 at RBC Capital
After meeting with Summit's CFO, RBC Capital thinks that the stock can rise based on what it sees as potential improving price/volume trends, margin expansion, and strategic M&A. RBC keeps an Outperform rating on the shares.
11/16/16
BOFA
11/16/16
DOWNGRADE
Target $26
BOFA
Neutral
Summit Materials downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded Summit Materials to Neutral from Buy and raised its price target to $26 from $23. Analyst Timna Tanners said building materials companies shares have soared in anticipation of increased infrastructure spending following Trump's victory and believes the bull case is now reflected in Summit Materials' valuation.
10/11/16
GSCO
10/11/16
DOWNGRADE
GSCO
Neutral
Summit Materials downgraded to Neutral from Buy at Goldman
Goldman analyst Jerry Revich downgraded Summit Materials to Neutral based on expectations for slowing growth in the 4th year of the construction recovery. The analyst lowered his price target to $21 from $22 on Summit shares.
11/16/16
BOFA
11/16/16
DOWNGRADE
BOFA
Neutral
Summit Materials downgraded to Neutral from Buy at BofA/Merrill
WRK WestRock
$50.89

-0.03 (-0.06%)

09/23/16
DBAB
09/23/16
UPGRADE
Target $90
DBAB
Buy
Packaging Corp. upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Debbie Jones upgraded Packaging Corp. of America (PKG) to Buy citing an "improved earnings trajectory" following the TimBar acquisition. The analyst raised her price target for the shares to $90 from $77. Jones this morning also upgraded KapStone (KS) to Buy. She raised her estimates across the Paper & Packaging space to reflect the likelihood of success for the October containerboard price hike initiative. Jones also raised her price target for Buy-rated WestRock to $53 from $50 and Hold-rating International Paper (IP) to $50 from $42.
08/25/16
DBAB
08/25/16
NO CHANGE
DBAB
International Paper to increase containerboard prices, says Deutsche Bank
Deutsche Bank analyst Debbie Jones says International Paper (IP) is increasing containerboard prices by $50 per ton effective October 1st, citing trade contacts. The analyst notes that she is not aware of similar moves from other producers, but suspects additional announcements may come. Nonetheless, Jones questions whether or not the full amount will be achieved and if an increase is sustainable. A successful increase would be beneficial not only for International Paper, but also for WestRock (WRK), Packaging Corp (PKG) and KapStone (KS), the analyst says, noting that Greif (GEF) also has modest exposure to containerboard. In afternoon trading, International Paper's stock has gained over 4% to $48.59 per share.
09/22/16
GSCO
09/22/16
INITIATION
Target $53
GSCO
Neutral
WestRock initiated with a Neutral at Goldman
Goldman analyst Brian Maguire initiated WestRock with a Neutral and a $53 price target.
10/24/16
DBAB
10/24/16
NO CHANGE
DBAB
Deutsche sees Containerboard stocks outperforming today
Pulp & Paper Week over the weekend reflected $40 of the $50 per ton October 1 containerboard price hike, Deutsche Bank analyst Debbie Jones tells investors in a research note. PPW noted that producers are making "solid progress" in implementing the increase, the analyst adds. Given investor concern that a smaller increase would be reflected, Jones expects Containerboard stocks to outperform the marke today. She believes the price raise is a near-term positive for WestRock (WRK), KapStone (KS), Packaging Corp. (PKG) and International Paper (IP).

TODAY'S FREE FLY STORIES

CNX

CONSOL

$21.30

-0.48 (-2.20%)

, CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

15:02
12/10/16
12/10
15:02
12/10/16
15:02
Conference/Events
CONE Midstream participates in an analyst and investor day »

Management participates…

CNX

CONSOL

$21.30

-0.48 (-2.20%)

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

, CNX

CONSOL

$21.30

-0.48 (-2.20%)

14:59
12/10/16
12/10
14:59
12/10/16
14:59
Conference/Events
CONSOL to host analyst and investor day »

Analyst and Investor Day…

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

CNX

CONSOL

$21.30

-0.48 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BG

Bunge

$73.36

-0.04 (-0.05%)

14:54
12/10/16
12/10
14:54
12/10/16
14:54
Conference/Events
Bunge to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

14:50
12/10/16
12/10
14:50
12/10/16
14:50
Conference/Events
AMD to host Summit Ridge a "Zen"-based CPU at New Horizon »

President & CEO Su…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$50.76

0.61 (1.22%)

14:41
12/10/16
12/10
14:41
12/10/16
14:41
Conference/Events
Arthur J. Gallagher to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NYT

New York Times

$14.10

0.15 (1.08%)

14:34
12/10/16
12/10
14:34
12/10/16
14:34
Conference/Events
Detroit Economic Club to hold a luncheon meeting »

Mark Thompson, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$27.16

0.89 (3.39%)

14:28
12/10/16
12/10
14:28
12/10/16
14:28
Conference/Events
AstraZeneca has a luncheon meeting with Philadelphia Securities Association »

Luncheon Meeting being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Feb

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

, GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
UT Health Science Center to hold a symposium »

2016 San Antonio Breast…

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

MYGN

Myriad Genetics

$17.40

0.41 (2.41%)

RDUS

Radius Health

$43.94

-3.13 (-6.65%)

OCX

OncoCyte

$6.15

0.05 (0.82%)

ABBV

AbbVie

$61.54

0.64 (1.05%)

BAYRY

Bayer

$100.04

1.14 (1.15%)

CELG

Celgene

$113.47

0.41 (0.36%)

CLDX

Celldex

$3.75

0.01 (0.27%)

DNA

Bought by RHHBY

HRTX

Heron Therapeutics

$14.90

-0.55 (-3.56%)

PFE

Pfizer

$31.70

0.76 (2.46%)

PBYI

Puma Biotechnology

$36.50

0.05 (0.14%)

TSRO

TESARO

$129.97

-1.57 (-1.19%)

NSTG

NanoString

$21.79

-0.35 (-1.58%)

NVS

Novartis

$69.74

2.15 (3.18%)

NVTA

Invitae

$7.24

0.28 (4.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

BBSI

Barrett Business

$62.30

1.85 (3.06%)

, BREW

Craft Brew

$16.65

0.45 (2.78%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
Roth Capital to hold a conference »

5th Annual ROTH Utah…

BBSI

Barrett Business

$62.30

1.85 (3.06%)

BREW

Craft Brew

$16.65

0.45 (2.78%)

CHKE

Cherokee

$11.10

-0.35 (-3.06%)

DFBG

Differential Brands

$3.20

0.25 (8.47%)

DLA

Delta Apparel

$20.77

-0.39 (-1.84%)

ESCA

Escalade

$13.65

-0.15 (-1.09%)

FLKS

Flex Pharma

$6.29

-0.01 (-0.16%)

KONA

Kona Grill

$12.75

0.05 (0.39%)

LNDC

Landec

$15.05

-0.25 (-1.63%)

MEET

MeetMe

$5.63

0.16 (2.93%)

MITK

Mitek Systems

$6.50

0.35 (5.69%)

MB

MINDBODY

$20.70

-0.25 (-1.19%)

OSIS

OSI Systems

$78.17

1.22 (1.59%)

PLNT

Planet Fitness

$21.01

-0.07 (-0.33%)

ROX

Castle Brands

$0.75

0.0309 (4.30%)

PRTS

U.S. Auto Parts

$3.33

0.09 (2.78%)

RSYS

RadiSys

$4.77

0.11 (2.36%)

SWHC

Smith & Wesson

$21.07

-0.16 (-0.75%)

VSTO

Vista Outdoor

$38.62

-1.24 (-3.11%)

WMAR

West Marine

$9.41

0.13 (1.40%)

ZAGG

ZAGG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

, CSCO

Cisco

$30.06

0.11 (0.37%)

18:32
12/09/16
12/09
18:32
12/09/16
18:32
Hot Stocks
Arista Networks favored in ITC initial determination on four of six patents »

Arista Networks (ANET)…

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

CSCO

Cisco

$30.06

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

TKTDY

Takata Corporation

$10.70

0.05 (0.47%)

18:22
12/09/16
12/09
18:22
12/09/16
18:22
Periodicals
U.S. DOT looks to accelerate pace of Takata air bag replacements, Reuters says »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DV

DeVry

$31.90

0.9 (2.90%)

18:17
12/09/16
12/09
18:17
12/09/16
18:17
Hot Stocks
Breaking Hot Stocks news story on DeVry »

International Value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

18:10
12/09/16
12/09
18:10
12/09/16
18:10
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Cornerstone OnDemand has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$0.12

-0.0014 (-1.17%)

18:03
12/09/16
12/09
18:03
12/09/16
18:03
Hot Stocks
NYSE MKT says CEL-SCI noncompliant with certain listing requirements »

CEL-SCI reported on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$89.00

0.68 (0.77%)

18:01
12/09/16
12/09
18:01
12/09/16
18:01
Periodicals
Exxon CEO Tillerson emerges as top candidate for secretary of state, WSJ says »

Exxon Mobil CEO Rex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

17:58
12/09/16
12/09
17:58
12/09/16
17:58
Hot Stocks
H.B. Fuller announces restructuring, to eliminate, relocate 220 positions »

H.B. Fuller has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$287.77

-1.77 (-0.61%)

17:53
12/09/16
12/09
17:53
12/09/16
17:53
Periodicals
Biogen looks like a bargain, Barron's reports »

Biogen trades at just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$40.40

0.63 (1.58%)

17:42
12/09/16
12/09
17:42
12/09/16
17:42
Periodicals
Sanofi to lay off 20% of U.S. diabetes, cardiovascular staff, Bloomberg says »

The layoffs include parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

17:38
12/09/16
12/09
17:38
12/09/16
17:38
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Investor Praesidium said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TACO

Del Taco

$14.75

-0.39 (-2.58%)

17:34
12/09/16
12/09
17:34
12/09/16
17:34
Hot Stocks
Breaking Hot Stocks news story on Del Taco »

PW Acquisitions cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 09

    Dec

UNVR

Univar

$26.36

0.54 (2.09%)

, BXLT

Baxalta

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Univar names Eric Foster chief information officer »

Univar (UNVR) named Eric…

UNVR

Univar

$26.36

0.54 (2.09%)

BXLT

Baxalta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Breaking Hot Stocks news story on Parnell 

Parnell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$20.81

0.2 (0.97%)

, NVRO

Nevro

$76.38

-1.88 (-2.40%)

17:24
12/09/16
12/09
17:24
12/09/16
17:24
Hot Stocks
Boston Scientific files patent infringement suit against Nevro »

Nevro (NVRO) announced…

BSX

Boston Scientific

$20.81

0.2 (0.97%)

NVRO

Nevro

$76.38

-1.88 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RTN

Raytheon

$146.30

0.14 (0.10%)

17:21
12/09/16
12/09
17:21
12/09/16
17:21
Hot Stocks
Raytheon awarded $101.9M government contract »

Raytheon Co., Goleta,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$8.77

-0.16 (-1.79%)

17:18
12/09/16
12/09
17:18
12/09/16
17:18
Hot Stocks
CEMEX receives subpoena from SEC regarding Foreign Corrupt Practices Act »

On December 9, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.